Page 559 - fbkCardioDiabetes_2017

Cardio Diabetes Medicine 2017 535

BASAL INSULINS
APPROXIMATELY 8 MILLION PATIENTS
WORLDWIDE WITH T2DM RECEIVE BASAL INSULIN

T2DM Patients Treated
with Basal Insulin 1 (worldwide)

On basal insulin On basal insulin
but HbA 1C >7%

4 million
on Lantus ®

4 million
4 million
on other
basalinsulins 2

1. Adapted from IMS data; 2. Includes all types of basal insulins

Hypothesis: the large hydrodynamic size of BASAL INSULIN may
allow slow absorption of monomers predominantly via the
lymphatic system

1. Kaminskas LM et al. J Controlled Release 2013;168:200-8; 2. Kaminskas LM, Porter CJ. Adv Drug Del Rev 2011;63:890-900;
3. Kaminskas LM et al. J Control Release 2009;140:108-16; 4. Charman SA et al. Pharm Res 2001;18:1620-6

Cardio Diabetes Medicine